Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Return on Assets (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Return on Assets for 15 consecutive years, with 0.51% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 39.0% to 0.51% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.51%, a 39.0% decrease, with the full-year FY2025 number at 0.42%, down 30.0% from a year prior.
  • Return on Assets was 0.51% for Q4 2025 at Myriad Genetics, up from 0.57% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.01% in Q1 2022 to a low of 0.57% in Q3 2025.
  • A 5-year average of 0.18% and a median of 0.12% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: rose 24bps in 2021, then plummeted -39bps in 2025.
  • Myriad Genetics' Return on Assets stood at 0.02% in 2021, then plummeted by -354bps to 0.09% in 2022, then tumbled by -147bps to 0.23% in 2023, then soared by 47bps to 0.12% in 2024, then crashed by -322bps to 0.51% in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Return on Assets are 0.51% (Q4 2025), 0.57% (Q3 2025), and 0.47% (Q2 2025).